# US 2001/0034061 A1 · Methods for isolation and activation of, and control of differentiation from, stem and progenitor cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0034061 A1
- Document ID: US20010034061A1
- Status: Published application
- Kind: A1
- Application number: 09/773,824
- Filed: 2001-01-31
- Published: 2001-10-25
- Earliest claimed: 1998-11-18
- Assignees: California Institute of Technology
- Inventors: Marie Csete; John Doyle; Barbara Wold
- Web page: https://patentgrep.com/patent/US20010034061A1

## CPC

- C12N 5/0658: {Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts}
- A61K 38/1816: {Erythropoietin [EPO]}
- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- C12N 5/0619: {Neurons}
- C12N 5/0623: {Stem cells}
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C12N 2500/02: Atmosphere, e.g. low oxygen conditions
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2501/14: Erythropoietin [EPO]
- C12N 2503/02: Drug screening
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a method of isolating, maintaining, and/or enriching for stem or progenitor cells derived from diverse organ or tissue sources. The invention specifically teaches that these can be accomplished by the controlled use of subatmospheric oxygen culture, and that the precise oxygen level or levels must be determined empirically and/or by reference to physiologic levels within intact functioning organ or tissue.

## Claims

### Claim 1

A method culturing stem cells or progenitor cells, comprising the steps of:
a) obtaining a population of mammalian cells capable of forming a solid tissue containing at least one stem cell or progenitor cell, and
b) culturing the population of mammalian cells in suitable medium with the oxygen level selected to maintain or enhance the survival of the stem or progenitor cell or cell type, and
c) culturing the population of stem cells or progenitor cells for a time sufficient to maintain or enhance the survival of the stem cell or progenitor cell

### Claim 2

A method culturing stem cells or progenitor cells, comprising the steps of:
a) obtaining a population of mammalian cells capable of forming a solid tissue containing at least one stem cell or progenitor cell, and
b) culturing the population of mammalian cells in suitable medium with the oxygen level selected to maintain or enhance the proliferation of the stem or progenitor cell, and
c) culturing the population of stem cells or progenitor cells for a time sufficient to maintain or enhance the proliferation of the stem or progenitor cell

### Claim 3

A method of enriching stem cells or progenitor cells relative to one or more other cell types in a population of mammalian cells capable of forming a solid tissue comprising at least one stem cell or progenitor cell and one or more other cell types, comprising the steps of:
a) obtaining the population of mammalian cells containing at least one stem cell or progenitor cell and one or more other cell types, and
b) culturing the population of mammalian cells in suitable medium under subatmospheric oxygen conditions for a time sufficient to enrich stem cells or progenitor cells in the population relative to one or more other cell types in the population.

### Claim 4

A method of identifying a stem or progenitor cell in a population of cells, comprising the steps of:
a) obtaining the population of mammalian cells capable for forming a solid tissue containing at least one stem cell or progenitor cell and other cell types,
b) culturing the population of mammalian cells in suitable medium under subatmospheric conditions, and
c) identifying stem cells or progenitor cells in the population.

### Claim 5

A method of accelerating differentiation of a stem cell or a progenitor cell and/or the progeny of the stem or progenitor cell capable of forming a solid tissue, comprising culturing a stem or progenitor cell in suitable medium under subatmospheric oxygen conditions for a time sufficient to accelerate the developmental progression and/or differentiation of the stem cell or progenitor cell or its progeny into one or more types of cell that are more advanced in a developmental pathway or are more differentiated.

### Claim 6

A method of enhancing production of desired differentiated cells or cells at a more advanced stage in a developmental progression than are the starting stem cells or progenitor cells derived from a solid tissue, comprising
a) first culturing with subatmospheric oxygen conditions to expand the stem or progenitor cell population, and
b) then culturing the expanded population under subatmospheric oxygen conditions to encourage differentiation.

### Claim 7

A method of manipulating a differentiation pathway of a stem or progenitor cell, comprising the step of:
a) culturing a stem cell or a progenitor cell in suitable medium under subatmospheric oxygen conditions selected to obtain differentiated progeny, such that the percentage of at least one type of differentiated cell produced is increased relative to the percentage of at least one other type of differentiated cell which could ultimately be produced, and
b) optionally culturing the differentiated progeny in suitable medium under subatmospheric oxygen conditions, such that the differentiation progeny of step a) are further differentiated.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

The method of claim 1, 2, 3, 4, 5, 6, or 7, wherein the stem cell or progenitor cell is derived from skeletal muscle, neural tissue, bone, skin, liver, bone marrow, smooth muscle, or embryonic stem cells.

### Claim 9 (depends on 8)

The method of claim 8, wherein the stem cell or progenitor cell is derived from skeletal muscle, skin or neural tissue.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6)

The method of claim 1, 2, 3, 4, 5, 6, or 7, further comprising the step of transfecting the stem cell or progenitor cell with an expression vector comprising a DNA operably linked to a promoter.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6)

The method of claim 1, 2, 3, 4, 5, 6, or 7, further comprising the step of transfecting the stem cell or progenitor cell with an expression vector comprising a DNA or other synthetic or natural nucleic acid.

### Claim 12

A method for screening for a compound which affects the survival, proliferation or differentiation and/or regeneration of a stem cell or progenitor cell, comprising the steps of:
a) contacting a population of stem cells or progenitor cells capable of forming a solid tissue with the compound under subatmospheric conditions, and
b) monitoring the various cell populations for survival, proliferation and/or differentiation.
